We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Remitly
RELY
$5.14B
| $7.75M | ﹤0.01% |
677,151
+60,866
| +10% | +$631K |
|
|
ESGR
1627
DELISTED
Enstar Group
ESGR
| $7.75M | ﹤0.01% |
33,544
-5,578
| -14% | -$1.14M |
|
1628
Clarivate
CLVT
$1.16B
| $7.75M | ﹤0.01% |
929,033
-128,489
| -12% | -$1.21M |
|
1629
Alignment Healthcare
ALHC
$2.98B
| $7.72M | ﹤0.01% |
656,910
-17,167
| -3% | -$209K |
|
|
IRBT
1630
DELISTED
iRobot
IRBT
| $7.72M | ﹤0.01% |
160,497
-1,096
| -0.7% | -$57.9K |
|
1631
Wayfair
W
$14.6B
| $7.71M | ﹤0.01% |
234,444
+26,383
| +13% | +$921K |
|
1632
Papa John's
PZZA
$806M
| $7.7M | ﹤0.01% |
93,583
-7,698
| -8% | -$605K |
|
1633
Zillow
ZG
$7.63B
| $7.68M | ﹤0.01% |
246,021
+89,187
| +57% | +$2.92M |
|
1634
Orion
OEC
$409M
| $7.67M | ﹤0.01% |
430,978
+59,564
| +16% | +$1M |
|
1635
AdaptHealth
AHCO
$759M
| $7.67M | ﹤0.01% |
398,926
-238,631
| -37% | -$5.05M |
|
1636
JELD-WEN Holding
JELD
$164M
| $7.66M | ﹤0.01% |
794,006
+512,275
| +182% | +$4.97M |
|
1637
LCI Industries
LCII
$2.65B
| $7.65M | ﹤0.01% |
82,783
-16,837
| -17% | -$1.65M |
|
1638
Walker & Dunlop
WD
$1.53B
| $7.65M | ﹤0.01% |
97,516
-5,916
| -6% | -$497K |
|
1639
IDEAYA Biosciences
IDYA
$3.56B
| $7.61M | ﹤0.01% |
418,989
+152,173
| +57% | +$2.56M |
|
1640
Nurix Therapeutics
NRIX
$2.65B
| $7.58M | ﹤0.01% |
690,365
+137,709
| +25% | +$1.66M |
|
1641
PennyMac Financial
PFSI
$4.02B
| $7.57M | ﹤0.01% |
133,636
-14,526
| -10% | -$769K |
|
1642
Pebblebrook Hotel Trust
PEB
$2.05B
| $7.56M | ﹤0.01% |
564,729
-532,074
| -49% | -$8.13M |
|
|
BBBY
1643
Bed Bath & Beyond
BBBY
$442M
| $7.56M | ﹤0.01% |
429,519
+263,847
| +159% | +$5.67M |
|
1644
Kohl's
KSS
$2.19B
| $7.55M | ﹤0.01% |
298,999
-80,511
| -21% | -$2.28M |
|
1645
Park National Corp
PRK
$3.67B
| $7.54M | ﹤0.01% |
53,565
+2,095
| +4% | +$295K |
|
1646
Methode Electronics
MEI
$592M
| $7.51M | ﹤0.01% |
169,226
-17,472
| -9% | -$746K |
|
|
BLUE
1647
DELISTED
bluebird bio
BLUE
| $7.5M | ﹤0.01% |
54,218
-1,784
| -3% | -$251K |
|
|
ZUO
1648
DELISTED
Zuora, Inc.
ZUO
| $7.46M | ﹤0.01% |
1,173,107
-228,902
| -16% | -$1.62M |
|
1649
PTC Therapeutics
PTCT
$6.12B
| $7.45M | ﹤0.01% |
195,161
-16,209
| -8% | -$674K |
|
1650
IPG Photonics
IPGP
$3.84B
| $7.38M | ﹤0.01% |
77,956
-477
| -0.6% | -$42.8K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.